Athenex, Inc. Business Finance Contracts & Agreements
37 Contracts & Agreements
- Credit Agreements (10 contracts)
- Exchange Agreements (1)
- Financing Agreements (1)
- Loan Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (4)
- Security Agreements (2)
- Share Agreements (2)
- Stock Agreements (4)
- Underwriting Agreements (3)
- Warrant Agreements (5)
- Waiver to Credit and Guaranty Agreement, by and among Athenex, Inc., the Lenders party thereto, and Oaktree Fund Administration, LLC, as administrative agent for the Lenders,... (Filed With SEC on November 21, 2022)
- WARRANT AGENCY AGREEMENT (Filed With SEC on November 3, 2022)
- FORM OF COMMON STOCK PURCHASE WARRANT Athenex, Inc. (Filed With SEC on November 3, 2022)
- Sixth Amendment to Credit and Guaranty Agreement, by and among Athenex, Inc., the Lenders party thereto, and Oaktree Fund Administration, LLC, as administrative agent for the... (Filed With SEC on August 18, 2022)
- Limited Waiver under Revenue Interest Purchase Agreement, by and among ATNX SPV, LLC, Athenex, Inc., and the Purchaser parties thereto, dated as of August 14, 2022 (Filed With SEC on August 18, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 15, 2022)
- Underwriting Agreement, dated August 10, 2022, by and between the Company and SVB Securities LLC (Filed With SEC on August 15, 2022)
- Form of Salary Deduction and Stock Purchase Agreement (Filed With SEC on March 29, 2022)
- Third Amendment to Credit and Guaranty Agreement and First Amendment to the Warrants between Athenex and Oaktree, dated January 19, 2022 (Filed With SEC on March 16, 2022)
- Second Amendment to Credit and Guaranty Agreement between Athenex and Oaktree, dated December 14, 2021 (Filed With SEC on March 16, 2022)
- Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated January 7, 2022 (Filed With SEC on January 12, 2022)
- First Amendment and Limited Waiver to Credit and Guaranty Agreement between Athenex and Oaktree, dated June 3, 2021 (Filed With SEC on August 5, 2021)
- Asset Purchase and Sale Agreement dated as of September 1, 2020 by and between Athenex Pharmaceutical Division, LLC and Ingenus Pharmaceuticals, LLC (Filed With SEC on March 1, 2021)
- Assignment and Assumption dated as of August 4, 2020, by and among Athenex, Inc, as the borrower, Sagard Healthcare Royalty Partners, LP, OPB SHRP Co-Invest Credit Limited and... (Filed With SEC on November 5, 2020)
- Security Agreement dated as of August 4, 2020, by and between Athenex, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 5, 2020)
- Underwriting Agreement, dated September 9, 2020, by and between the Company and SVB Leerink LLC, RBC Capital Markets, LLC and Evercore Group L.L.C., as representatives of the... (Filed With SEC on September 10, 2020)
- Revenue Interest Financing Agreement (Filed With SEC on August 6, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on August 6, 2020)
- Registration Rights Agreement by and among Athenex, Inc. and the purchasers named therein, dated as of June 19, 2020 (Filed With SEC on August 6, 2020)
- Security Agreement dated as of June 19, 2020, by and among Athenex, Inc., the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto,... (Filed With SEC on August 6, 2020)
- Credit Agreement and Guaranty dated as of June 19, 2020, by and among Athenex, Inc., the subsidiary guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on June 22, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on June 22, 2020)
- Form of Registration Rights Agreement (Filed With SEC on December 5, 2019)
- Share Purchase Agreement, by and among Athenex, Inc., M. Kingdon Offshore Master Fund, LP, Schonfeld Strategic 460 Fund LLC, Point72 Associates, LLC, J. Goldman Master Fund, L.P.,... (Filed With SEC on December 5, 2019)
- Amendment No. 2 to Credit Agreement by and between Athenex, Inc. and Perceptive Advisors LLC, dated as of August 5, 2019 (Filed With SEC on August 7, 2019)
- Amendment No. 1 to Credit Agreement by and between Athenex, Inc. and Perceptive Advisors LLC, dated as of April 22, 2019 (Filed With SEC on August 7, 2019)
- Supplemental Agreement to Athenex Pharmaceutical Base Project Located in the Chongqing Maliu Riverside Development Zone Agreement with Chongqing Maliu Riverside Development and... (Filed With SEC on August 7, 2019)
- Form of Registration Rights Agreement (Filed With SEC on May 6, 2019)
- Share Purchase Agreement, by and among Athenex, Inc., Perceptive Life Sciences Master Fund, Ltd., venBio Select Fund LLC, OrbiMed Partners Master Fund Limited, and The Biotech... (Filed With SEC on May 6, 2019)
- Registration Rights Agreement dated as of July 3, 2018 by and between Athenex, Inc. and Perceptive Life Sciences Master Fund, Ltd (Filed With SEC on August 14, 2018)
- Senior Secured Term Loan Agreement, dated as of June 30, 2018, by and between Athenex, Inc. and Perceptive Advisors LLC (Filed With SEC on July 2, 2018)
- Stock Purchase Agreement, dated as of June 29, 2018 by and between Athenex, Inc. and Perceptive Life Sciences Master Fund, Ltd (Filed With SEC on July 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on January 22, 2018)
- ATHENEX, INC. 2017EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 2, 2017)
- CREDIT SUISSE SECURITIES (USA) LLC DEUTSCHE BANK SECURITIES INC. J.P. MORGAN SECURITIES LLC UNDERWRITING AGREEMENT ATHENEX, INC. [] Sharesof Common Stock Underwriting Agreement (Filed With SEC on June 2, 2017)
- ASSET PURCHASE AGREEMENT between ATHENEX, INC. and AMPHASTAR PHARMACEUTICALS,INC. Dated as of February 1, 2017 TABLE OF CONTENTS (Filed With SEC on May 12, 2017)
- KINEX PHARMACEUTICALS, INC. 2013 COMMON STOCK OPTION PLAN (Filed With SEC on May 12, 2017)
